Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASCEND-P: Daprodustat for anemia in pediatric chronic kidney disease
jRCT2041220113Completed
- Sponsor
- GSK
- Start
- Sep 2023
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of daprodustat in anemia of renal disease, sponsored by GSK. Primary endpoint: Safety of daprodustat (overall and by age group). Started Sep 2023; status: completed.
02
Drugs
daprodustat
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on jRCT2041220113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2041220113.